BAY1817080
Sponsors
Bayer
Conditions
Clinical Trials, Phase I as TopicCoughDiabetic Neuropathic PainEndometriosisEndometriosis Related PainHealthy VolunteersNeuropathic Pain Associated With Diabetic Peripheral NeuropathyOveractive Bladder
Phase 1
First in Human Study to Investigate the Safety and Tolerability, Pharmacokinetics, Itraconazole Drug-drug-interaction and Food Effect of BAY1817080
CompletedNCT02817100
Start: 2016-07-22End: 2017-08-23Updated: 2017-09-06
Repeat Doses of BAY 1817080 in Healthy Males & Proof of Concept in Chronic Cough Patients
CompletedNCT03310645
Start: 2017-12-07End: 2019-06-19Updated: 2023-01-26
Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants
CompletedNCT04265781
Start: 2020-02-15End: 2020-09-20Updated: 2023-01-26
Study to Gather Information on the Influence of BAY1817080 on the Electrical Activity of the Heart Recorded by an Electrocardiogram in Healthy Male and Female Participants
CompletedNCT04423744
Start: 2020-06-18End: 2021-01-21Updated: 2022-01-24
Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function
CompletedNCT04454424
Start: 2020-07-23End: 2021-12-15Updated: 2023-01-20
Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function
CompletedNCT04471337
Start: 2020-08-12End: 2021-05-06Updated: 2024-03-26
A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)
CompletedNCT04487431
Start: 2020-08-05End: 2021-02-11Updated: 2023-01-26
A Trial to Learn How BAY1817080 Moves Into, Through and Out of the Body and How Safe it is in Healthy Chinese Men
CompletedNCT04802343
Start: 2021-04-02End: 2021-10-29Updated: 2022-10-19
Phase 2
Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)
CompletedNCT04545580
Start: 2020-09-16End: 2022-01-21Updated: 2022-12-22
Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough
CompletedNCT04562155
Start: 2020-10-02End: 2021-07-23Updated: 2022-08-18
Study to Gather Information How Well Three Different Doses of BAY1817080 Given Twice Daily Over 12 Weeks Work in Comparison to an Inactive Pill (Placebo) and Elagolix in Women Suffering From Pain Related to a Condition Where the Tissue That Usually Grows Inside the Womb Grows Outside of the Womb
TerminatedNCT04614246
Start: 2021-01-29End: 2022-05-03Updated: 2023-08-01
A 2-part Trial to Learn More About How BAY1817080 Works, How Safe it is, and What the Right Dose is for Participants With Diabetic Neuropathic Pain
TerminatedNCT04641273
Start: 2021-01-22End: 2021-10-18Updated: 2022-12-12